Clinical Trial Update: NHLBI Type II Coronary Intervention Study [Phase 3]

View source ↗

Summary

This update notes that the NHLBI Type II Coronary Intervention Study, a Phase 3 clinical trial, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Artery Disease
• Familial Hypercholesterolemia
• Heart Diseases
• Myocardial Infarction
• Myocardial Ischemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED